CERRISSA HUGIE: Open Payments
NPI 1538695846 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,616 in 139 payments from 17 companies in 2025. Trend: 2023 $3,703 · 2024 $3,171 · 2025 $2,616
Food & beverage: $2,504Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $344 |
| Vanda Pharmaceuticals Inc. | 15 | $337 |
| ABBVIE INC. | 26 | $286 |
| Axsome Therapeutics, Inc. | 12 | $261 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $254 |
| Lundbeck LLC | 10 | $218 |
| Alkermes, Inc. | 12 | $200 |
| Otsuka America Pharmaceutical, Inc. | 11 | $175 |
| Neurocrine BioSciences, Inc. | 5 | $132 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $130 |
Products named: REXULTI, HETLIOZ, VRAYLAR, Auvelity, CAPLYTA, ARISTADA, INGREZZA, TRINTELLIX.
Industry payments across SC — which companies pay providers there.
